Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Item Type
      Item Type
      Clear All
      Item Type
  • Subject
      Subject
      Clear All
      Subject
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
14 result(s) for "Lupton, Oliver"
Sort by:
Selection and processing of calibration samples to measure the particle identification performance of the LHCb experiment in Run 2
Since 2015, with the restart of the LHC for its second run of data taking, the LHCb experiment has been empowered with a dedicated computing model to select and analyse calibration samples to measure the performance of the particle identification (PID) detectors and algorithms. The novel technique was developed within the framework of the innovative trigger model of the LHCb experiment, which relies on online event reconstruction for most of the datasets, reserving offline reconstruction to special physics cases. The strategy to select and process the calibration samples, which includes a dedicated data-processing scheme combining online and offline reconstruction, is discussed. The use of the calibration samples to measure the detector PID performance, and the efficiency of PID requirements across a large range of decay channels, is described. Applications of the calibration samples in data-quality monitoring and validation procedures are also detailed.
Compatibility and combination of world W-boson mass measurements
The compatibility of W -boson mass measurements performed by the ATLAS, LHCb, CDF, and D0 experiments is studied using a coherent framework with theory uncertainty correlations. The measurements are combined using a number of recent sets of parton distribution functions (PDF), and are further combined with the average value of measurements from the Large Electron–Positron collider. The considered PDF sets generally have a low compatibility with a suite of global rapidity-sensitive Drell–Yan measurements. The most compatible set is CT18 due to its larger uncertainties. A combination of all m W measurements yields a value of m W = 80 , 394.6 ± 11.5  MeV with the CT18 set, but has a probability of compatibility of 0.5% and is therefore disfavoured. Combinations are performed removing each measurement individually, and a 91% probability of compatibility is obtained when the CDF measurement is removed. The corresponding value of the W boson mass is 80 , 369.2 ± 13.3  MeV, which differs by 3.6 σ from the CDF value determined using the same PDF set.
Studies of d⁰→k⁰sh+h'-decays at the lhcb experiment
This thesis documents two studies of the neutral charm meson system using the LHCb detector, and gives an overview of the numerous changes made to the LHCb software trigger in advance of Run 2 of the LHC. In the first analysis, amplitude models are applied to studies of the resonance structure in D0 → K0SK−π+ and D0 → K0SK+π− decays using proton-proton collision data, corresponding to an integrated luminosity of 3.0 fb−1, collected during Run 1 of the LHC. Relative magnitude and phase information is determined, and coherence factors and related observables are computed for both the whole phase space and a restricted region of 100 MeV/c2 around the K*(892)± resonance. Two formulations for the Kπ S-wave are used, both of which give a good description of the data. The ratio of branching fractions B (D0→ K0SK+π−) /B (D0→ K0SK−π+) is measured to be 0.655 ± 0.004 (stat) ± 0.006 (syst) over the full phase space and 0.370 ± 0.003 (stat) ± 0.012 (syst) in the restricted region. A search for CP violation is performed using the amplitude models and no significant effect is found. Predictions from SU(3) flavour symmetry for K*(892)K amplitudes of different charges are compared with the amplitude model results, and marginal agreement is found. The second study estimates the sensitivity to D0–D0 mixing and indirect CP violation parameters that can be achieved using a model-independent technique and the samples of D0→ K0SK+K− decays recorded by LHCb in Run 1 and Run 2 of the LHC. These studies show that constraints on these parameters could be significantly improved by an analysis of the anticipated Run 2 dataset.
Electroweak scale physics & exotic searches at LHCb
The LHCb experiment has a broad and varied physics programme, extending far beyond its core set of flavour physics measurements. This contribution summarises recent electroweak scale measurements and searches for exotic states in the dimuon final state.
Compatibility and combination of world W-boson mass measurements
The compatibility of W-boson mass measurements performed by the ATLAS, LHCb, CDF, and D0 experiments is studied using a coherent framework with theory uncertainty correlations. The measurements are combined using a number of recent sets of parton distribution functions (PDF), and are further combined with the average value of measurements from the Large Electron-Positron collider. The considered PDF sets generally have a low compatibility with a suite of global rapidity-sensitive Drell-Yan measurements. The most compatible set is CT18 due to its larger uncertainties. A combination of all mW measurements yields a value of mW = 80394.6 +- 11.5 MeV with the CT18 set, but has a probability of compatibility of 0.5% and is therefore disfavoured. Combinations are performed removing each measurement individually, and a 91% probability of compatibility is obtained when the CDF measurement is removed. The corresponding value of the W boson mass is 80369.2 +- 13.3 MeV, which differs by 3.6 sigma from the CDF value determined using the same PDF set.
Compatibility and combination of world W-boson mass measurements
The compatibility of W-boson mass measurements performed by the ATLAS, LHCb, CDF, and D0 experiments is studied using a coherent framework with theory uncertainty correlations. The measurements are combined using a number of recent sets of parton distribution functions (PDF), and are further combined with the average value of measurements from the Large Electron-Positron collider. The considered PDF sets generally have a low compatibility with a suite of global rapidity-sensitive Drell-Yan measurements. The most compatible set is CT18 due to its larger uncertainties. A combination of all mW measurements yields a value of mW = 80394.6 +- 11.5 MeV with the CT18 set, but has a probability of compatibility of 0.5% and is therefore disfavoured. Combinations are performed removing each measurement individually, and a 91% probability of compatibility is obtained when the CDF measurement is removed. The corresponding value of the W boson mass is 80369.2 +- 13.3 MeV, which differs by 3.6 sigma from the CDF value determined using the same PDF set.
Selection and processing of calibration samples to measure the particle identification performance of the LHCb experiment in Run 2
Since 2015, with the restart of the LHC for its second run of data taking, the LHCb experiment has been empowered with a dedicated computing model to select and analyse calibration samples to measure the performance of the particle identification (PID) detectors and algorithms. The novel technique was developed within the framework of the innovative trigger model of the LHCb experiment, which relies on online event reconstruction for most of the datasets, reserving offline reconstruction to special physics cases. The strategy to select and process the calibration samples, which includes a dedicated data-processing scheme combining online and offline reconstruction, is discussed. The use of the calibration samples to measure the detector PID performance, and the efficiency of PID requirements across a large range of decay channels, is described. Applications of the calibration samples in data-quality monitoring and validation procedures are also detailed.
Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review
The surge in cases of severe COVID-19 has resulted in clinicians triaging intensive care unit (ICU) admissions in places where demand has exceeded capacity. In order to assist difficult triage decisions, clinicians require clear guidelines on how to prioritise patients. Existing guidelines show significant variability in their development, interpretation, implementation and an urgent need for a robust synthesis of published guidance. To understand how to manage which patients are admitted to ICU, and receive mechanical ventilatory support, during periods of high demand during the COVID-19 pandemic, a systematic review was performed. Databases of indexed literature (Medline, Embase, Web of Science, and Global Health) and grey literature (Google.com and MedRxiv), published from 1 January until 2 April 2020, were searched. Search terms included synonyms of COVID-19, ICU, ventilation, and triage. Only formal written guidelines were included. There were no exclusion criteria based on geographical location or publication language. Quality appraisal of the guidelines was performed using the Appraisal of Guidelines for Research and Evaluation Instrument II (AGREE II) and the Appraisal of Guidelines for Research and Evaluation Instrument Recommendation EXcellence (AGREE REX) appraisal tools, and key themes related to triage were extracted using narrative synthesis. Of 1902 unique records identified, nine relevant guidelines were included. Six guidelines were national or transnational level guidance (UK, Switzerland, Belgium, Australia and New Zealand, Italy, and Sri Lanka), with one state level (Kansas, USA), one international (Extracorporeal Life Support Organization) and one specific to military hospitals (Department of Defense, USA). The guidelines covered several broad themes: use of ethical frameworks, criteria for ICU admission and discharge, adaptation of criteria as demand changes, equality across health conditions and healthcare systems, decision-making processes, communication of decisions, and guideline development processes. We have synthesised the current guidelines and identified the different approaches taken globally to manage the triage of intensive care resources during the COVID-19 pandemic. There is limited consensus on how to allocate the finite resource of ICU beds and ventilators, and a lack of high-quality evidence and guidelines on resource allocation during the pandemic. We have developed a set of factors to consider when developing guidelines for managing intensive care admissions, and outlined implications for clinical leads and local implementation.
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified the first strongly supported LOAD susceptibility genes since the discovery of the involvement of APOE in the early 1990s. We have now exploited these GWAS datasets to uncover key LOAD pathophysiological processes. We applied a recently developed tool for mining GWAS data for biologically meaningful information to a LOAD GWAS dataset. The principal findings were then tested in an independent GWAS dataset. We found a significant overrepresentation of association signals in pathways related to cholesterol metabolism and the immune response in both of the two largest genome-wide association studies for LOAD. Processes related to cholesterol metabolism and the innate immune response have previously been implicated by pathological and epidemiological studies of Alzheimer's disease, but it has been unclear whether those findings reflected primary aetiological events or consequences of the disease process. Our independent evidence from two large studies now demonstrates that these processes are aetiologically relevant, and suggests that they may be suitable targets for novel and existing therapeutic approaches.